nsideContent">

Webinars

CBMTG is excited to announce the launch of monthly multidisciplinary webinars to the blood and marrow transplant community in 2009!

What is a webinar?

A webinar is a form of web conferencing whereby participants view presentation slides online and received audio via phone line from live presenters. Participants and speakers only require internet and phone access; therefore, webinars provide informative, timely and cost-effective training. Multiple participants at one institution can benefit from the same webinar through enabling a speakerphone and communal monitor/projector. This multidisciplinary application typically lasts 1 hour and can consist of more than one speaker. Questions from the audience are usually addressed at the end of the presentations thereby providing an interactive learning medium. Reduced webinar rates will be offered to CBMTG members.

Should you be unable to attend a webinar, CD copies are also available for purchase.

Please Click Here to View Webinar Sponsorship Opportunities.

Upcoming Webinars

---

---

September 22, 2010
12pm ET

Mike Halpenny received his diploma in Biochemistry at Algonquin College in 1985 followed by Canadian registration as a Medical Laboratory Technologist in 1992. In 1998 Mike received his Quality Management for Healthcare Professionals Certificate from the Canadian Healthcare Association.
Mike is the Charge Technologist at the Canadian Blood Services Ottawa Stem Cell Processing Laboratory and is a member of the CBMTG Lab Committee, an AABB Cellular Therapy Product Manufacturing committee member as well as a FACT Inspector.

Registration Now Open!

Early Registration (Deadline September 15, 2010):
Members: $75 plus tax
Non-members: $90 plus tax

Late Registration (September 16-17, 2010):
Members: $90 plus tax
Non-Members $105 plus tax

Click Here to Register Online

Click Here to Download a PDF Registration Form

---

October 27, 2010
12pm ET

Expanding Options and Current Challenges in Autologous PBPC Harvests

Ronan Foley, MD, FRCPC
Director of the Stem Cell Laboratory, Hamilton Health Sciences

- Upfront identification of patients at risk

- Treatment options and Algorithms

- New Agents and the Future

Dr. Ronan Foley is a clinical haematologist and Director of the Stem Cell Laboratory, Hamilton Health Sciences. Over the past 4 years Dr. Foley has acted as Chair of the Clinical Trials Network of the Canadian Bone Marrow Transplant Group (CBMTG). An Associate Professor of Pathology and Molecular Medicine at McMaster University, Dr. Foley completed his medical and subspecialty training in Hamilton and Toronto. He completed a Terry Fox Fellowship in the Centre of Gene Therapeutics, McMaster University. During this time, he became interested in the evaluation of cellular gene transfer in the context of cancer immunotherapy, which led to his current research focus: the development of therapeutic cancer vaccines.In addition to fundamental research the clinical laboratory has been active in novel clinical stem cell manipulations for haploidentical transplants and photodynamic therapy for GVHD and tumor cell purging (NHL).

Registration Now Open!

Early Registration (Deadline October 20, 2010):
Members: $75 plus tax
Non-members: $90 plus tax

Late Registration (October 21-22, 2010):
Members: $90 plus tax
Non-Members $105 plus tax

Click Here to Register Online

Click Here to Download a PDF Registration Form

---

PAST WEBINARS:

First CBMTG Webinar:

"Challenges Faced with Cord Blood Transplants"

Donna Wall, MD, Director Blood and Marrow Transplant Program
Marie Tulloch, MLT (CSMLS) Senior LaboratoryTechnologist, Cellular Therapy Lab
CancerCare Manitoba
Wednesday, February 25, 2009

CD copies of the webinar available for purchase:
Members: $75 plus tax
Non-members: $90 plus tax
Click here to download a PDF CD order form

---

March Webinar:

“Sexuality in Patients Undergoing Hematopoietic Stem Cell Transplantation”

Reanne Booker, RN BScN, MN, Nurse Practitioner
Alberta Bone Marrow Transplant Program
Wednesday, March 25, 2009
12 PM EDT

Objectives:

* review the impact of stem cell transplantation on sexuality
* discuss assessment/management of sexual health concerns
* discuss resources available for healthcare providers

CD copies of the webinar will also be available for purchase:
Members: $75 plus tax
Non-members: $90 plus tax

Click here to download a PDF CD order form

---

April Webinar:

"Canadian Blood Services OneMatch Stem Cell and Marrow Network Update"

Sue Smith, Executive Director, OneMatch Stem Cell and Marrow Network
April 22, 2009
12:00pm EDT

Objectives:

*increase overall awareness of the Onematch Stem Cell and Marrow Network
*share and discuss the latest statistics and data on unrelated hematopoietic stem cell activities in Canada and Internationally
*provide and update on the status of the business case for establishment of a national public umbilical cord blood bank

CD copies of the webinar will also be available for purchase:
Members: $75 plus tax
Non-members: $90 plus tax

Click here to download a PDF CD order form

---

May Webinar:

"HLA Typing: Cases We Don't See Everyday"

Cindy Ellison, PhD, D(ABHI)
HLA Laboratory
CancerCare Manitoba

Geoff Cuvelier, MD, FRCPC
Pediatric Blood and Marrow Transplant Program
CancerCare Manitoba

May 27, 2009
12:00pm EDT

Objectives:

* Review HLA basics: structure, funcion, nomenclature, and typing methods.

*Using instructive cases, present approaches to family and extended kindred typing, recombination and mismatch evaluation.

CD copies of the webinar will also be available for purchase:
Members: $75 plus tax
Non-members: $90 plus tax

Click here to download a PDF CD order form

---

June Webinar:

"Stem Cell Transplantation: Past, Present and Future"

Dr. Thomas Nevill
Clinical Director
Leukemia/BMT Program of British Columbia

June 24, 2009
12:00pm EDT

Supported by:

Objectives are to provide the participant with an understanding of:

1.The scientific basis of SCT.

2.The actual SCT process, from cell collection to infusion of the product.

3.The complications and expected outcomes for SCT recipients.

4.The new developments in the field of SCT.

CD copies of the webinar will also be available for purchase:
Members: $75 plus tax
Non-members: $90 plus tax

Click here to download a PDF CD order form

---

September Webinar:

Geoff Cuvelier, MD, FRCPC
Pediatric Blood and Marrow Transplant Program
CancerCare Manitoba
Wednesday, September 23, 2009
12 PM EDT

Objectives:

1. Review basic biology of NK cells

2. Review potential role for NK cells in graft-versus-leukemia effect

3. Review results and controversies in clinical trials looking at NK cell KIR mismatching in allogeneic HSCT.

CD copies of the webinar will also be available for purchase:
Members: $75 plus tax
Non-members: $90 plus tax

Click here to download a PDF CD order form

---

October 2009 Webinar:

Young Adults with Cancer

Geoff Eaton
Founder and Executive Director
Young Adult Cancer Canada

Geoff Eaton is a very proud Newfoundlander, who graduated from Memorial University of Newfoundland, where he studied Business Administration. During his final year of studies he created Exeter Imaging, a marketing services company. Today he lives in St. John’s, NL, with his wife Karen and daughters Adia and Mira, where he is the founder and Executive Director of Young Adult Cancer Canada.

Originally diagnosed with Leukemia in 1998 Geoff received several rounds of chemotherapy, full body radiation, a bone marrow transplant from his Dad and later spent a month in Intensive Care on life support. After rebuilding physically and emotionally from his ICU experience Geoff turned his cancer challenge into opportunity with the establishment of Young Adult Cancer Canada (YACC).

As YACC celebrated its first anniversary of operation Geoff's leukemia relapsed forcing an adjustment in personal and professional plans. After additional chemotherapy and a stem cell transplant, again from his Dad, Geoff resumed limited work activities.

Since those early years YACC’s vision has evolved considerably, as has the program offering for young adults dealing with cancer.

Today YACC is the only Canadian cancer organization nationally focused on inspiring, informing and supporting young adults dealing with cancer. YACC hosts a web-based peer support community for young adult survivors, annual retreats, a survivor conference and delivers Touch Yourself, Trust Yourself, an early detection education program for young adults.

Geoff is a member of the Canadian Association of Professional Speakers and has shared his message of hope with over 65,000 people from across Canada. His story has been featured in numerous national television, radio and newspaper outlets.

Professional goals focus on filling the education and support gap for young adults dealing with cancer through the growth of Young Adult Cancer Canada, inspiring the masses to take control of their health and their life in his professional speaking and working to improve the Canadian healthcare system as a patient advocate.

Committed to volunteering, Geoff is a member of the National Survivorship Working Group and the Adolescent Young Adult Task Force, both initiatives of the Canadian Partnership Against Cancer.

Geoff is personally devoted to staying healthy, growing old with his wife and daughters and the constant pursuit of the sometimes elusive state of balance.

You will not meet another person who embodies their motto as much as Geoff Eaton… Always… Live life, love life.

CD copies of the webinar:
Members: $75 plus tax
Non-members: $90 plus tax

Click here to download a PDF CD order form

---

November Webinar:

Stephen Couban, MD
Director, Bone Marrow Transplant Program
Queen Elizabeth II Health Sciences Centre
Wednesday, November 18, 2009
12:00 pm EST

Learning Objectives:

1. To understand the different sources of cells for allografting
2. To understand the potential complications of marrow harvesting and peripheral blood harvesting for the donor
3. To understand the potential advantages and disadvantages of marrow and peripheral blood for the recipient
4. To consider future directions in this field.

Stephen Couban received a Bachelor of Science degree from McGill University in 1982 and his M.D. from Dalhousie University in 1986.He completed a residency in Internal Medicine at Dalhousie University in Halifax and went on to complete a fellowship in Hematology at McMaster University in Hamilton.He also undertook two years of specialty training in bone marrow transplantation at the Princess Margaret Hospital in Toronto as a National Cancer Institute of Canada Terry Fox Research Fellow.

In 1997, Stephen Couban joined the Department of Medicine at Dalhousie University and the Capital District Health Authority in Halifax, Nova Scotia. He is Service Chief in the Division of Hematology and Director of the Blood and Marrow Transplant Program. He is also Service Chief of the Department of Medicine Medical Teaching Unit.His research interests have focused on allografting and in particular on exploration of different types of grafts including G-CSF stimulated allogeneic peripheral blood allografts and G-CSF stimulated bone marrow allografts. Stephen Couban is Past-President of the Canadian Blood and Marrow Transplant Group, Secretary of the Canadian Hematology Society and Co-Chair of the Hematology Site Group of the National Cancer Institute of Canada Clinical Trials Groups.

CD copies of the webinar will also be available for purchase:
Members: $75 plus tax
Non-members: $90 plus tax

---

December 2009 Webinar:

Silvy Lachance, MD FRCPC CSPQ
Director Stem Cell Transplant Program
Maisonneuve-Rosemont Hospital
Wednesday, December 16, 2009
12:00 pm EST

Despite recent advance in the understanding of its pathophysiology, acute Graft versus Host Disease remains a major complication of allogeneic Stem Cell Transplantation. While initial treatment is relatively standardized, the approach to steroid refractory aGVHD continues to be a real challenge. No clear guidelines have emerged from the literature and comparative study between treatment alternatives is sadly lacking. The goal of the lecture is to review the efficiency of the different therapeutic options focusing on treatment selection according to the site or organ involved. An algorithm of treatment will be proposed.

Dr. Silvy Lachance received